Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
San Diego’s Halozyme Therapeutics Seeks Biotech Cure for Cellulite Denise Gellene 02/09/10 San Diego
Infinity’s New CEO, Veteran Dealmaker, Seeks to Deliver on Company’s Early Promise Luke Timmerman 02/09/10 Boston
Tragara Raises $5M Bruce V. Bigelow 02/08/10 San Diego
Zafgen’s Mysterious Weight Loss Drug Advances Into First Trial for Obese Women Luke Timmerman 02/08/10 Boston
Alkermes Unveils Cheaper, Easier Technique for Making Drugs Last Longer in Blood Luke Timmerman 02/04/10 Boston
Carl Icahn Nominates Scripps Researcher to Biogen Idec Board, BrainCells Pursues New Drug Combo for Depression, Illumina Adds to Oxford Nanopore Investment, & More San Diego Life Sciences News Bruce V. Bigelow 02/04/10 San Diego
Google Pours “Incredible” Computing Power into Antibody Drug Discovery With Adimab Luke Timmerman 02/03/10 Boston
Cell Therapeutics FDA Panel Primer: What You Need to Know to Be Ready Next Week Luke Timmerman 02/03/10 Seattle
All Eyes On Ironwood IPO, Icahn Seeks Biogen Board Seats, Boston Scientific Settles with J&J, & More Boston-Area Life Sciences News Erin Kutz 02/03/10 Boston
BrainCells Inc. Maps Out Next Steps for Novel Depression Drug Luke Timmerman 02/02/10 San Diego
Amira Mixes Small Biotech Irreverence, With Big Pharma Rigor, To Create New Lung Drugs Luke Timmerman 01/28/10 San Diego
Biogen Idec Advances First Regenerative MS Medicine into Human Study Luke Timmerman 01/27/10 Boston
San Diego’s Life Sciences CROs—The Map of Clinical Research Organizations Bruce V. Bigelow 01/27/10 San Diego
Prometheus Positions for IPO, Licenses Novartis Drug Bruce V. Bigelow 01/26/10 San Diego
San Diego’s Top 10 Venture Deals of 2009 Bruce V. Bigelow 01/26/10 San Diego
San Diego’s Halozyme Injects New Life into Old Drugs Denise Gellene 01/26/10 San Diego
Amylin Braces for Big Event of 2010, the (Hoped-For) Approval of Once-Weekly Diabetes Drug Luke Timmerman 01/22/10 San Diego
Somaxon Revises FDA Application Denise Gellene 01/21/10 San Diego
Elevation Pharmaceuticals Raises $30M to Develop Aerosol Treatments for Pulmonary Diseases Bruce V. Bigelow 01/21/10 San Diego
FDA to Rule on Genzyme Drug in Six Months Ryan McBride 01/21/10 Boston
Merck’s Alan Sachs, on RNAi’s Big Challenge: Delivery, Delivery, Delivery Luke Timmerman 01/21/10 National
6 Goals for Fixing Genzyme: Xconomy’s Q&A With Relational Investors’ Ralph Whitworth Bruce V. Bigelow 01/21/10 San Diego
A Baldness Update from Histogen; Sequenom Agrees to Settle a Suit; the Life Sciences Job Outlook Improves & More San Diego Life Sciences News Denise Gellene 01/21/10 San Diego
Roche Prepares to Make Devices for Drug Using Halozyme Therapeutics Technology Denise Gellene 01/21/10 San Diego
Acucela Enters Fast-Growth Phase As Macular Degeneration Drug Advances to Key Trial Luke Timmerman 01/20/10 Seattle
Crinetics Enters Collaboration Agreement With Ferring Research Institute Bruce V. Bigelow 01/14/10 San Diego
Once Destined for Bankruptcy, Adventrx Pharmaceuticals Sets New Course With Reformulated Drugs Bruce V. Bigelow 01/13/10 San Diego
Gilead Deepens Roots in Seattle, Seeks Long-Term Payoff From Lung Disease Research Luke Timmerman 01/13/10 Seattle
DataSphere and Halosource Get Funded, Sage Signs Up Pfizer, Zymo Raises $90M, & More Seattle-Area Deals News Gregory T. Huang 01/12/10 Seattle
BIND Hires New CEO, Raises $11M Ryan McBride 01/11/10 Boston
Page 1 of 19 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.